WO2025210464 - MODIFIED RELEASE FORMULATIONS OF VILOXAZINE
National phase entry is expected:
Publication Number
WO/2025/210464
Publication Date
09.10.2025
International Application No.
PCT/IB2025/053325
International Filing Date
29.03.2025
Title **
[English]
MODIFIED RELEASE FORMULATIONS OF VILOXAZINE
[French]
FORMULATIONS À LIBÉRATION MODIFIÉE DE VILOXAZINE
Applicants **
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD
Inventors
PULLAGURLA, Manik Reddy
ARUTLA, Srinivas
RANGISETTY, Jagadeesh Babu
Priority Data
202441027907
04.04.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1955 | |
| EPO | Filing, Examination, Granting | 11624 | |
| Japan | Filing, Examination, Granting | 2015 | |
| South Korea | Filing, Examination, Granting | 1789 | |
| USA | Filing, Examination, Granting | 8940 |
Total:
26,323
Contact Us
Abstract[English]
Modified release formulations of viloxazine and methods of administering the same are disclosed.[French]
L'invention concerne des formulations à libération modifiée de viloxazine et des procédés d'administration de ces formulations.